Navigation Links
Surface Logix, Inc. to Present at the Piper Jaffray Health Care Conference
Date:11/26/2007

BOSTON, Nov. 26 /PRNewswire/ -- Surface Logix, Inc. today announced that Jim Mahoney, President and Chief Executive Officer, will present an update of the company's drug development pipeline at the 19th Annual Piper Jaffray Health Care Conference being held November 27-29, 2007 at The Pierre Hotel in New York City. Mr. Mahoney's presentation will take place on Wednesday, November 28, 2007 at 2:50 PM EST.

Surface Logix currently has two programs in human clinical trials with a third program in the IND preparation stage. Mr. Mahoney will discuss the latest results for SLx-2101 and SLx-4090. SLx-2101, a second-generation PDE5 inhibitor designed to address cardiovascular indications, is currently in two separate Phase 2a trials, one in hypertension and another in Raynaud's syndrome. SLx-4090, a first-in-class enterocyte-specific MTP inhibitor for the treatment of dyslipidemia and potentially other indications, is also in Phase 2a.

About Surface Logix, Inc.

Surface Logix, Inc. uses its expertise in biophysical chemistry to create and develop novel small molecule drugs (NCEs) with superior drug-like properties that are clearly differentiated from competitive products. The company is advancing multiple internal programs focused primarily on cardiovascular, metabolic, oncologic and fibrotic diseases. For more information, please visit http://www.surfacelogix.com.

Contact:

Leland Webster, Ph.D., M.B.A.

Surface Logix Inc.

Vice President, Corporate Development

617.746.8520

Media:

Sarah Cavanaugh

MacDougall Biomedical Communications, Inc.

scavanaugh@macbiocom.com

508.647.0209


'/>"/>
SOURCE Surface Logix, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine technology :

1. Keeping the Data Center Clean: ATEN Launches Industry-First KVM Switches with Antimicrobial Nanocoating to Protect Products from Bacteria Surviving on Surfaces
2. Surface Logix Presents Positive Phase 1 Repeat-Dose Trial Data on SLx-4090 at The 16th International Symposium on Drugs Affecting Lipid Metabolism
3. Cantel Medical Corp.s Crosstex Subsidiary Addresses School MRSA Concerns With SaniTyze(TM) Brand Hand Sanitizer and Sanitex(R) Surface Disinfecting Line of Products
4. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
5. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
6. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
7. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
8. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
9. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
10. Pre-clinical Data on Recent Advances with HIV VLP Vaccine Presented at AIDS Vaccine 07 Conference
11. Iomai Announces Data from Phase 2 Field Study of Travelers Diarrhea Vaccine Accepted for Presentation at ICAAC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/19/2013)... , May 19, 2013  The non-surgical ... low temperature radiofrequency (RF) energy is effective in ... or reduces the need for medication 10 years ... presented today at the Digestive Disease Week (DDW) ... Florida . "The sustained ...
(Date:5/18/2013)... The Open Paradigm Project, in collaboration ... Psychiatry , and leading organizations in the movement ... media campaign showcasing video testimonials by individuals negatively ... on pathology and illness rather than wellness and ... Association,s (APA) rollout of its latest revision of ...
(Date:5/17/2013)... , May 17, 2013 The power of ... important ways in which mankind depends on the plant ... Garden,s multifaceted exhibition Wild Medicine: Healing ... on view from May 18 through September 8, ... The featured exhibition,s many attractions include a re-creation ...
Breaking Medicine Technology:Stretta Procedure for GERD: Successful 10 Year Follow-Up Data Presented at Digestive Disease Week--Sustained Improvement, Long-Term Efficacy 2Stretta Procedure for GERD: Successful 10 Year Follow-Up Data Presented at Digestive Disease Week--Sustained Improvement, Long-Term Efficacy 3New Social Media Campaign Features Stories Of Individuals Who Rejected Psychiatric Diagnoses 2New Social Media Campaign Features Stories Of Individuals Who Rejected Psychiatric Diagnoses 3Wild Medicine On View at The New York Botanical Garden Through Sept. 8 2
... FOLD ) today announced that John F. Crowley ... Chairman in order to devote more time to interests related ... role as Executive Chairman, Mr. Crowley will continue to perform ... will advise the current Amicus management team on corporate strategy ...
... The board of directors of Eli Lilly and Company (NYSE: ... second quarter of 2011 of $0.49 a share on outstanding ... 10, 2011 to shareholders of record at the close of ... innovation-driven corporation, is developing a growing portfolio of pharmaceutical products ...
Cached Medicine Technology:Amicus Therapeutics Announces Transition of John F. Crowley from Chairman and Chief Executive Officer to Executive Chairman 2
(Date:5/20/2013)... (PRWEB) May 20, 2013 The ... Confectionery, Snacks, Breakfast Cereals, Baking Mixes & Flour, ... Conventional) & Geography — Global Trends & Forecasts ... product market with analysis and forecasting of the ... also identifies the driving and restraining factors for ...
(Date:5/20/2013)... 2013 B. E. Smith, the ... healthcare providers, has been retained to lead a ... Oswego Hospital in Oswego, N.Y. The top executive ... Smith has recently placed more than 900 healthcare ... a 164-bed, Joint Commission-accredited, acute care facility offering ...
(Date:5/20/2013)... Irritable Bowel Syndrome, or IBS, is commonly characterized ... habits, and is a difficult condition in which the ... of the colon may overreact to food, stress, exercise ... to an infection or a stressful life event. The ... a protein composite found in foods processed from wheat ...
(Date:5/20/2013)... 2013 The main objective for the present ... into a single comprehensive report. The objective was to ... this industry. Thus, it is timely to examine the ... an urgent need in the life science industry for technologies ... in a high-throughput, multiplex and low-cost way. Proteomic technologies ...
(Date:5/20/2013)... May 20, 2013 Pain Free ... relief products is excited to release a line ... arthritis pain relief. These magnetic health bracelets for ... with gemstones. Customers often report pain relief in ... demonstration at shows. , "Having made magnetic bracelets ...
Breaking Medicine News(10 mins):Health News:Gluten-Free Products Market to Reach $6,206.2 Million by 2018 at a CAGR of 10.2% - New Report by MarketsandMarkets 2Health News:Gluten-Free Products Market to Reach $6,206.2 Million by 2018 at a CAGR of 10.2% - New Report by MarketsandMarkets 3Health News:Oswego Hospital Retains B. E. Smith to Recruit New COO 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Offers improved hCG Diets With More Beneficial Nutritional Content, Possibly Offering Relief for Painful Symptoms of IBS 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Offers improved hCG Diets With More Beneficial Nutritional Content, Possibly Offering Relief for Painful Symptoms of IBS 3Health News:Proteomics Market - Mass Spectrometry & Biochips 2017 Forecast & Analysis in New Research Report at ReportsnReports.com 2Health News:Proteomics Market - Mass Spectrometry & Biochips 2017 Forecast & Analysis in New Research Report at ReportsnReports.com 3Health News:Handmade Magnetic Bracelets with Gemstones Announced by Pain Free Living 2
... , OAKBROOK TERRACE, Ill., Sept. 21 ... 2009 recipients of the annual John M. Eisenberg Patient Safety and Quality ... feature a new international category. , , ... INDIVIDUAL ACHIEVEMENT , Gary S. ...
... , Awardees will work with industry ... , WASHINGTON, Sept. 21 The U.S. Food ... stimulate the development and availability of medical devices for children. ... , , A panel of six experts with ...
... , Research features from Mayo Clinic , ... the fall issue of Discovery,s Edge, Mayo Clinic,s research magazine. ... wish. Reprinting is allowed with proper attribution. Please include the following subscription ... Discovery,s Edge for subscription information. , ...
... , , MONTREAL, ... integrated absence & disability management, today announced the release ... to comply with complex and overlapping FMLA (Family and ... regulations. Presagia,s ADA Toolkit will supplement Presagia,s Leave ...
... Dalton ... adding Formulation Development to its list of integrated capabilities. , ... Toronto, Ontario (PRWEB) September 21, 2009 -- ... by adding Formulation Development to its list of integrated capabilities. , , ...
... , , ... of emergency department (ED) clinical documentation tools, today announced it ... recent recommendations of the Centers for Disease Control and Prevention ... the T-System Web site ( www.tsystem.com/h1n1flu ), now ...
Cached Medicine News:Health News:2009 John M. Eisenberg Patient Safety and Quality Award Recipients Announced 2Health News:2009 John M. Eisenberg Patient Safety and Quality Award Recipients Announced 3Health News:2009 John M. Eisenberg Patient Safety and Quality Award Recipients Announced 4Health News:FDA Awards Three Grants Designed to Stimulate Development of Pediatric Medical Devices 2Health News:FDA Awards Three Grants Designed to Stimulate Development of Pediatric Medical Devices 3Health News:Discovery's Edge Fall Issue -- http://discoverysedge.mayo.edu/ 2Health News:Discovery's Edge Fall Issue -- http://discoverysedge.mayo.edu/ 3Health News:Presagia Solution Helps Employers Navigate Overlapping ADA and FMLA Regulations 2Health News:Presagia Solution Helps Employers Navigate Overlapping ADA and FMLA Regulations 3Health News:Dalton Pharma Services Adds Formulation Development Services 2Health News:T-System Updates Free Clinician H1N1 Templates to Latest CDC Guidelines, Adds Discharge Instructions 2Health News:T-System Updates Free Clinician H1N1 Templates to Latest CDC Guidelines, Adds Discharge Instructions 3
Duet Lumbar Allografts are comprised of a raised cancellous inner core providing biomechanical properties for rapid healing. Specially designed instruments facilitate the insertion of Duet Allografts...
Lumbar Allograft with Osteoactive advantage. Promotes bone formation and faster incorporation. Derived from the proven technology behind Grafton DBM. Maintains structural integrity and strength....
Seletz-Gelpi Laminectomy Retractor, self-retaining with arms bent at right angles....
Scoville-Haverfield Hemilaminectomy Retractor...
Medicine Products: